Novo Nordisk | NVO - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
ANI Pharmaceuticals USD 114.5M 8.38M 2026-03
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Bausch Health Companies USD 979M 55M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Canopy Growth CAD 53.08M 8.3M 2025-12
Corcept Therapeutics USD 2.88M 338K 2026-03
Drreddys Laboratories INR 40.46B 3.64B 2025-12
Eli Lilly USD 3.58B 205M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Merck USD 2.94B 380M 2026-03
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.46B 83M 2026-03
Novo Nordisk DKK 13.6B 1.55B 2026-03
Novo Nordisk DKK 1.95B 10.94B 2025-06
Pacira USD 50.74M 3.89M 2026-03
Perrigo USD 643.7M 103.7M 2026-03
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 140.76M 9.53M 2026-03
Sanofi EUR 3.67B 621M 2026-03
Supernus Pharmaceuticals USD 49.04M 1.5M 2026-03
Zoetis USD 672M 71M 2026-03